I agree that this site is using cookies. You can find further informations here.
X
Bazinet, Alexandre
53  results:
?
1

Prognostic risk signature in patients with acute myeloid le..:

Bataller, Alex ; Bazinet, Alexandre ; DiNardo, Courtney D....
Blood Advances.  8 (2024)  4 - p. 927-935 , 2024
Link: https://doi.org/10.1182/..
 
?
2

Reduced dose azacitidine plus venetoclax as maintenance the..:

Bazinet, Alexandre ; Kantarjian, Hagop ; Bataller, Alex...
The Lancet Haematology.  11 (2024)  4 - p. e287-e298 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Hematopoietic stem cells with granulo-monocytic differentia..:

Rodriguez-Sevilla, Juan Jose ; Ganan-Gomez, Irene ; Ma, Feiyang...
Nature Communications.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
4

Targetable genetic abnormalities in patients with acute mye..:

Bataller, Alex ; DiNardo, Courtney D. ; Bazinet, Alexandre...
American Journal of Hematology.  99 (2024)  4 - p. 792-796 , 2024
Link: https://doi.org/10.1002/..
 
?
5

Oral decitabine and cedazuridine plus venetoclax for older ..:

Bazinet, Alexandre ; Garcia-Manero, Guillermo ; Short, Nicholas...
The Lancet Haematology.  11 (2024)  4 - p. e276-e286 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Therapy-related chronic myelomonocytic leukemia does not ha..:

Bataller, Alex ; Gener-Ricos, Georgina ; Almanza-Huante, Emmanuel...
Blood Advances.  8 (2024)  11 - p. 2695-2706 , 2024
Link: https://doi.org/10.1182/..
 
?
7

Lower intensity therapy with cladribine/low dose cytarabine..:

Senapati, Jayastu ; Kantarjian, Hagop M. ; Bazinet, Alexandre...
Cancer.  , 2024
Link: https://doi.org/10.1002/..
 
?
8

Outcomes and genetic dynamics of acute myeloid leukemia at ..:

Bataller, Alex ; Kantarjian, Hagop ; Bazinet, Alexandre...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
9

Oral decitabine plus cedazuridine and venetoclax in patient..:

Bataller, Alex ; Montalban-Bravo, Guillermo ; Bazinet, Alexandre...
The Lancet Haematology.  11 (2024)  3 - p. e186-e195 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Characteristics and clinical outcomes of patients with myel..:

Bataller, Alex ; Loghavi, Sanam ; Gerstein, Yoheved...
American Journal of Hematology.  98 (2023)  11 - p. 1780-1790 , 2023
Link: https://doi.org/10.1002/..
 
?
11

P736: ANALYSIS OF RESPONSE RATES AND OUTCOMES IN ERYTHROID-..:

Bazinet, Alexandre ; Arani, Naszrin ; Chien, Kelly...
HemaSphere.  7 (2023)  S3 - p. e1254385 , 2023
Link: https://doi.org/10.1097/..
 
?
12

Evolving trends and outcomes in older patients with acute m..:

Bazinet, Alexandre ; Kantarjian, Hagop ; Arani, Naszrin...
American Journal of Hematology.  98 (2023)  9 - p. 1383-1393 , 2023
Link: https://doi.org/10.1002/..
 
?
13

S172: PHASE 1/2 STUDY OF ORAL DECITABINE/CEDAZURIDINE IN CO..:

Bataller, Alex ; Bazinet, Alexandre ; Venugopal, Sangeetha...
HemaSphere.  7 (2023)  S3 - p. e18588ff , 2023
Link: https://doi.org/10.1097/..
 
?
14

Automated quantification of measurable residual disease in ..:

Bazinet, Alexandre ; Wang, Alan ; Li, Xinmei...
Cytometry Part B: Clinical Cytometry.  , 2023
Link: https://doi.org/10.1002/..
 
?
15

P723: CLINICAL AND MOLECULAR ASSOCIATIONS WITH OUTCOMES IN ..:

Bazinet, Alexandre ; Prasad Desikan, Sai ; LI, Ziyi...
HemaSphere.  7 (2023)  S3 - p. e554617b , 2023
Link: https://doi.org/10.1097/..
 
1-15